AUTL
Autolus Therapeutics plc
Company Overview
| Mkt Cap | $409.86M | Price | $1.55 |
| Volume | 1.50M | Change | +2.65% |
| P/E Ratio | -1.9 | Open | $1.52 |
| Revenue | $10.1M | Prev Close | $1.51 |
| Net Income | $-220.7M | 52W Range | $1.11 - $4.12 |
| Div Yield | N/A | Target | $9.59 |
| Overall | 37 | Value | 60 |
| Quality | 42 | Technical | 10 |
No chart data available
Stock Overview
Updated DailyAutolus Therapeutics plc (AUTL) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.55 with a market capitalization of $409.86 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows AUTL with a volume of 1.50 million shares. The stock opened up 0.66% from yesterday's close of $1.51. Current analyst estimates project earnings of $-0.93 per share for this year, with next year targeting $-0.69.
AUTL demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for AUTL include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 518.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AUTL | $1.55 | +2.6% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Autolus Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW